 "Sun Pharma gains ahead of board meet to mull share buyback proposal")
Sun Pharmaceutical Industries was trading higher by 2% at Rs 757 on the BSE, ahead of the board meeting today to consider proposal for buy back of equity shares of the company.
On May 30, the board of directors of pharmaceutical company decided to hold the meeting on June 23, 2016 for evaluating a proposal of buy back of equity shares of the company.
However, since then, the stock had underperformed the market by falling 9% as compared to unchanged in the S&P BSE Sensex.
The stock is currently trading close to its 52-week low of Rs 706 on the BSE, touched on November 24, 2015 in intra-day trade. It hit a 52-week high of Rs 965 on August 20, 2015.
As of March 2016, promoter holding in Sun Pharma stands at 54.97%. While LIC holds 3.83% stake, Government of Singapore owns 1.65% in the pharma company.
Till 11:35 AM, a combined 2.38 million shares changed hands on the counter on the BSE and NSE.
On May 30, the board of directors of pharmaceutical company decided to hold the meeting on June 23, 2016 for evaluating a proposal of buy back of equity shares of the company.
However, since then, the stock had underperformed the market by falling 9% as compared to unchanged in the S&P BSE Sensex.
The stock is currently trading close to its 52-week low of Rs 706 on the BSE, touched on November 24, 2015 in intra-day trade. It hit a 52-week high of Rs 965 on August 20, 2015.
As of March 2016, promoter holding in Sun Pharma stands at 54.97%. While LIC holds 3.83% stake, Government of Singapore owns 1.65% in the pharma company.
Till 11:35 AM, a combined 2.38 million shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%